If you’re looking for opportunity in a crazed market, follow the insiders.
After all, who knows the company better than an insider – the CEO, CFO, COO, officers, employees, and directors? If they’re buying a sizable number of shares, it’s often a good idea to start looking into why and perhaps follow them into the stock.
That’s because they’re typically privy to information on new products, competition, and the operating environment of the firm. We have to consider that insiders who are buying their stock wouldn’t put up their own money unless they believed the move would be profitable. Of course, it’s not always wise to base your own buying decisions solely on the actions of insiders.
Here are a few stocks insiders have been buying.
|
Company: Leggett & Platt (SYM: LEG) In late May, director Mark Blinn bought 6,000 shares of LEG at an average price of $10.74 for about $64,440. This was around the time the stock gapped lower on poor earnings. It was also around the time the company appointed a new President and CEO. |
Smallcaps Daily
The Most Promising Biotech Stock for Your Radar in 2024
This Innovative Biotech Company Is Taking A Novel, Game-Changing Approach To Eradicating Many Respiratory Viruses Once And For All Including Tripledemic Threat Of COVID, RSV, FLU…
What’s in store for biotech in 2024?
Discover how this innovative biotech firm is taking a novel, game-changing approach to eradicating many viruses, including Covid-19!
|
Company: Integra Life Sciences (SYM: IART) |
Paradigm Press
AI “wealth window” will close June 25
James Altucher here. I’ve been called a “genius investor” by my fans…and an “eccentric millionaire” by some others.
I think it’s because I make big predictions that tend to come true and today, I’m making my boldest prediction ever!
Next-generation AI technology will create the first $100 TRILLION industry. And there could be trillions available to those investors who get in early.
I put together this personal video [HERE]… Revealing the AI stocks I believe could turn as little as $10,000 into $1 MILLION over the next few years.
>>HERE is everything you need now<<
|
Company: GeneDX Holdings (SYM: WGS) Trending higher with solid earnings, WGS is another strong stock to watch. Just recently, a 10% owner bought 170,000 shares at an average price of $20.15 for about $3.42 million. According to Katherine Stueland, Chief Executive Officer of GeneDx, “Our team’s successful execution in the first quarter gives us the confidence to raise full year 2024 revenue guidance to between $235-$245 million and reiterate our expectation to reach profitability in 2025.” |
